Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung...
Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer
About this item
Full title
Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer
Author / Creator
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Journal title
Thoracic cancer, 2023-05, Vol.14 (13), p.1217-1217
Language
English
Formats
Publication information
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Subjects
More information
Alternative Titles
Full title
Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_924d2496122c4ed88553bfa0769aeb06
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_924d2496122c4ed88553bfa0769aeb06
Other Identifiers
ISSN
1759-7706
E-ISSN
1759-7714
DOI
10.1111/1759-7714.14877
